Aptus Pharma Ltd Q1 FY27 results deck summary

Results deck of 21 Aug 2026, summarised by AI from the filing.

FY26 revenue from operations ₹46.57 cr, up 89.7%, with PAT ₹4.62 cr, up 49.0%.

Key takeaways

1. FY26 revenue Revenue from operations ₹46.57 cr (FY25: ₹24.56 cr, +89.7%).
2. H2 revenue H2 FY26 revenue ₹32.20 cr vs H1 FY26 ₹14.38 cr.
3. Growth driver Asset-light model with WHO-GMP contract manufacturers redirects resources to sales and brand building.
4. Margin risk Gross profit margin fell to 54.1% in FY26 from 63.2% in FY25.

Original filing on BSE

Aptus Pharma Ltd earnings call, investor presentation and press release summaries

• Q1 FY27: Results deck (21 Aug 2026)
• Q4 FY26: Results press release (28 Apr 2026)
• Other events: Strategy deck (7 Feb 2026)